Life Sciences

Marlborough-based pharmaceutical company Sumitomo Pharma America, a U.S. subsidiary of Japanese parent company Sumitomo Pharma, is set to lay off 53 employees, as the company continues to reduce its workforce.

“Central Massachusetts will complement the existing strengths in Greater Boston, accelerating the momentum for the Commonwealth to lead the emerging biomanufacturing sector in the U.S.,” the report reads.

Less than four months after hiring its first CEO in company history, Natick-based biopharmaceutical company AffyImmune Therapeutics has a new leader.

The Milford production line in the largest-ever expansion for global biopharmaceutical manufacturer Rentschler Biopharma is now fully operational, a major milestone as the Germany-based company ramps up its contract work.

Lifeward, the Marlborough-based manufacturer of mobility assistive devices formerly known as ReWalk Robotics, has named the executive vice president of a Waltham medical device company to the chairman of its board of directors.

The property, located at 100 Industrial Drive, was purchased in a deal finalized on Thursday.

Marlborough medical device manufacturing firm Boston Scientific looks to soon add stroke prevention treatment to its portfolio, as the manufacturer has entered into a $1.16 billion agreement to purchase California-based medical device company Silk Road Medical.

The Massachusetts Manufacturing Pulse Survey, designed to capture trends, challenges and perspectives within the manufacturing sector, is open and accepting entries through the end of August. 

The oral tablet, known as ALZ-801 or Valiltramiprosate, intends to block the formation of neurotoxic molecules in the brain believed to be drivers of the disease.

A New York nonprofit has donated $2.2 million to UMass Chan Medical School in Worcester to help fund gene therapy research on a rare and fatal genetic disorder largely impacting children and young adults.